| Heading: |
Shingles: Vaccination |
| Question ID: |
1745807 |
| UIN: |
17008 |
| House: |
Commons |
| Date tabled: |
2024-11-29 |
| Asking Member ID: |
5078 |
| Asking Member display name: |
Pippa Heylings
|
| Asking Member handle: |
pippaheylings
|
| Asking Member Twitter reference: |
@pippaheylings
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of shingles vaccines for all over 65s. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-09 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
1506 |
| Answering Member display name: |
Andrew Gwynne
|
| Answering Member handle: |
GwynneMP
|
| Answering Member Twitter reference: |
@GwynneMP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
From September 2023, the routine shingles vaccination programme changed from the Zostavax vaccine to the two dose Shingrix vaccine, to better protect individuals from the effects of shingles, provide better clinical outcomes, and reduce pressures on the h... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |